• Chronic hepatitis
  • Lynch Syndrome Multi Gene Panel (MLH1, MSH2, MSH6, PMS2 and EPCAM), Genomic Unity®
  • Targeted Gene Mutation Panel, Solid Organ Neoplasm (PancreaSeq)
  • Epidermal Growth Factor Receptor (EGFR) Gene Mutation Analysis
  • Methylation Cancer Marker Detection in Cell-free Circulating Tumor DNA (Northstar Select and Response™)
  • Minimal Residual Disease (MRD) for Early Detection of Cancer Recurrence (Signatera™, Haystack MRD™)
  • LiquidHALLMARK Multi Cancer Panel
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /OncoExTra (Oncomap™ ExTra) for Metastatic Cancer
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References

OncoExTra (Oncomap™ ExTra) for Metastatic Cancer
Medical Test

Diseases (32)
Access to OncoExTra (Oncomap™ ExTra) for Metastatic Cancer is restricted.
Loading...